Perflow Medical Expands Product Portfolio with First Clinical Use of the Stream17 Dynamic Neuro-Thrombectomy Net NETANYA, Israel, April 29, 2021 /PRNewswire/ -- Perflow Medical, a private, Israeli-based innovator for neurovascular treatments, today announced the first successful clinical use of the Stream17 Dynamic Neuro-Thrombectomy Net, a lower profile device designed for more tortuous anatomy, to effectively treat hemorrhagic and ischemic stroke patients. Built on the proprietary CEREBRAL NET technology, the Stream17 device is the latest product portfolio addition that also includes the recently commercialized Cascade17 Dynamic Non-Occlusive Remodeling Net for coil embolization of intracranial aneurysms. These low-profile product offerings further expand the range of brain vessels that can now be treated with Perflow's unique CEREBRAL NET technology. The first clinical procedures were successfully completed by Prof. Karlis Kupcs, head of Radiology at the Pauls Stradins Clinical University Hospital in Riga, Latvia.